Highly relevant cancer-based real-world data populations for clinical research.
Our database is updated regularly, allowing users to unlock the most relevant applications of clinical research:
Browse related research, case studies and other resources that highlight examples of how RWD is being used today.
At COTA, we curate regulatory-grade oncology RWD with the most relevance for our life sciences and provider partners, whether that involves supporting regulatory filings or research questions. We cannot unlock the full value of RWD without the highest-quality collection and curation methodology, and we are powering a revolution in the development of new cancer therapies to bring clarity to cancer care.
The right cohorts after applying inclusion/exclusion criteria at the right volumes
Representativeness across real-world and clinical trial populations
Coverage across geographies of interest
We have a responsibility to drive the use of RWD by consistently improving our data and demonstrating its utility. Our data has been used to support FDA and EMA submissions, explain care patterns, understand patient outcomes, and much more – and we anticipate the number of use cases to multiply in the coming years as RWD is explored and leveraged by more and more innovators in the industry.
Interested in learning more about how we can transform cancer care together?